itmn

InterMune Soaring 90% in Early Pre-Market on European Commit

agency, chmp, commission, committee, disease, drug, ema, esbriet, eu, european, fibrosis, human, idiopathic, intermune, ipf, itmn, lung, markets, medicinal, medicines, mild, products, pulmonary, treatment, use

InterMune (ITMN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for Esbriet (pi

By FNN Staff
root@fnn-online.com

Latest News from FNNO

Wolverine World Wide Looks to Continue t...

Wolverine World Wide (NYSE:WWW) traded today at a new 52-week high of $32.42. Approxim ...

Recent 52-Week Low Surpassed in Shares o...

Windstream (NASDAQ:WIN) traded at a new 52-week low today of $7.36. So far today appro ...

Verint Systems: The Winning Streak Conti...

Shares of Verint Systems (NASDAQ:VRNT) traded today at $63.48, breaking its 52-week hig ...

Watch for Continued Losses in Shares of ...

Shares of Vivo Participacoes (NYSE:VIV) traded today at $14.66, breaking its 52-week lo ...

Shares of Vascular Solutions Have Risen ...

Vascular Solutions (NASDAQ:VASC) traded at a new 52-week high today of $31.35. Approxi ...

Titan International: The Losing Streak C...

Shares of Titan International (NYSE:TWI) traded at a new 52-week low today of $8.77. T ...

Tim Participacoes: The Losing Streak Con...

Shares of Tim Participacoes (NYSE:TSU) traded today at $16.29, breaking its 52-week low ...

Tidewater: The Losing Streak Continues (...

Tidewater (NYSE:TDW) traded today at a new 52-week low of $19.75. So far today approxi ...

Most Popular Video News